Naoki Inui Selected Research

Dermatomyositis (Dermatopolymyositis)

12/2023	Prognostic role of interferon-lambda 3 in anti-MDA5-positive dermatomyositis-associated ILD.
1/2021	Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis-associated ILD: A randomized, open-label trial.
12/2019	Successful classification of macrophage-mannose receptor CD206 in severity of anti-MDA5 antibody positive dermatomyositis associated ILD.
1/2019	Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody-positive Polymyositis/dermatomyositis-associated Interstitial Lung Disease: A Propensity Score-matched Analysis.
1/2019	Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.
12/2016	Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
1/2015	Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control study.
1/2015	A case of treatment with voriconazole for chronic progressive pulmonary aspergillosis in a patient receiving tacrolimus for dermatomyositis-associated interstitial lung disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naoki Inui Research Topics

Disease

31	Idiopathic Pulmonary Fibrosis 02/2024 - 06/2005
31	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 09/2003
28	Neoplasms (Cancer) 04/2024 - 04/2003
23	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2024 - 01/2008
16	Disease Progression 02/2024 - 03/2010
15	Nausea 04/2024 - 06/2014
15	Lung Neoplasms (Lung Cancer) 01/2024 - 09/2003
14	Vomiting 04/2024 - 06/2014
14	Chronic Obstructive Pulmonary Disease (COPD) 01/2023 - 12/2008
14	Asthma (Bronchial Asthma) 01/2023 - 08/2008
11	Inflammation (Inflammations) 01/2023 - 09/2006
11	Infections 02/2021 - 01/2005
9	Sarcoidosis (Schaumann Disease) 07/2022 - 01/2005
9	Adenocarcinoma of Lung 01/2022 - 01/2017
8	Dermatomyositis (Dermatopolymyositis) 12/2023 - 01/2015
7	Vascular Diseases (Vascular Disease) 01/2016 - 01/2008
6	Idiopathic Interstitial Pneumonias 01/2021 - 01/2008
6	Respiratory Insufficiency (Respiratory Failure) 01/2020 - 09/2002
5	Pulmonary Fibrosis (Fibrosing Alveolitis) 02/2024 - 01/2018
5	Pneumonia (Pneumonitis) 01/2023 - 09/2011
5	Fibrosis (Cirrhosis) 01/2021 - 08/2010
5	Lung Diseases (Lung Disease) 02/2015 - 04/2008
4	Rheumatoid Arthritis 01/2023 - 09/2008
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 08/2015
3	COVID-19 12/2023 - 01/2022
3	Pulmonary Hypertension 08/2023 - 11/2002
3	Death (Near-Death Experience) 04/2022 - 11/2020
3	Adenocarcinoma 01/2022 - 04/2003
3	Pneumothorax 01/2021 - 01/2020
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019 - 04/2003
3	Neoplasm Metastasis (Metastasis) 12/2018 - 08/2015
2	Hemangioma (Angioma) 06/2022 - 01/2022
2	Body Weight (Weight, Body) 02/2022 - 12/2021

Drug/Important Bio-Agent (IBA)

15	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 09/2012
12	Proteins (Proteins, Gene)FDA Link 02/2024 - 02/2008
11	Biomarkers (Surrogate Marker)IBA 11/2021 - 11/2011
11	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 04/2012
10	CollagenIBA 02/2024 - 01/2008
9	AntiemeticsIBA 04/2024 - 06/2014
9	Immune Checkpoint InhibitorsIBA 01/2024 - 05/2016
9	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019 - 09/2006
8	Dexamethasone (Maxidex)FDA LinkGeneric 11/2023 - 06/2014
7	AntibodiesIBA 02/2024 - 01/2008
7	ErbB Receptors (EGF Receptor)IBA 01/2021 - 08/2011
7	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 08/2011
6	CytokinesIBA 12/2023 - 09/2006
6	Cisplatin (Platino)FDA LinkGeneric 11/2023 - 01/2009
6	Bevacizumab (Avastin)FDA Link 01/2023 - 01/2016
6	Prednisolone (Predate)FDA LinkGeneric 01/2023 - 01/2014
5	Bleomycin (Blenoxane)FDA LinkGeneric 02/2024 - 01/2018
5	VaccinesIBA 12/2023 - 10/2009
5	Oxygen (Dioxygen)IBA 08/2023 - 03/2017
5	NivolumabIBA 01/2023 - 01/2019
5	pirfenidoneIBA 07/2021 - 01/2014
5	EnzymesIBA 01/2021 - 09/2008
5	Formoterol Fumarate (Oxis)FDA Link 01/2019 - 06/2012
5	Budesonide (Pulmicort)FDA LinkGeneric 01/2019 - 06/2012
5	Therapeutic UsesIBA 01/2015 - 05/2008
4	Palonosetron (Aloxi)FDA Link 11/2023 - 12/2015
4	Olanzapine (Zyprexa)FDA Link 01/2023 - 01/2019
4	PlatinumIBA 01/2023 - 08/2011
4	LigandsIBA 02/2022 - 06/2012
4	Tyrosine Kinase InhibitorsIBA 01/2022 - 07/2015
4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021 - 05/2008
4	ImmunosorbentsIBA 01/2021 - 09/2008
4	Mannose ReceptorIBA 02/2020 - 01/2018
4	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 01/2019 - 01/2015
4	Phenobarbital (Luminal)FDA Link 01/2019 - 06/2013
4	Tiotropium Bromide (Spiriva)FDA Link 02/2015 - 12/2008
3	SteroidsIBA 02/2024 - 09/2002
3	Docetaxel (Taxotere)FDA Link 01/2024 - 08/2013
3	Bronchodilator Agents (Bronchodilators)IBA 05/2022 - 01/2015
3	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 03/2022 - 07/2016
3	Neurokinin-1 Receptor AntagonistsIBA 03/2022 - 05/2017
3	AutoantibodiesIBA 01/2022 - 12/2016
3	LipidsIBA 01/2022 - 01/2005
3	Peroxidase (Myeloperoxidase)IBA 01/2021 - 05/2008
3	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 09/2013
3	Interleukin-17 (Interleukin 17)IBA 10/2018 - 01/2014
3	Aprepitant (Emend)FDA Link 09/2018 - 06/2014
3	Pemetrexed (MTA)FDA Link 06/2018 - 08/2013
3	AntigensIBA 01/2018 - 01/2005
3	Salmeterol Xinafoate (Serevent)FDA Link 01/2018 - 06/2012
3	Fluticasone (Cutivate)FDA LinkGeneric 01/2018 - 06/2012
3	Polymyxin B (Aerosporin)FDA LinkGeneric 02/2015 - 05/2008
3	anti-endothelial cell antibodyIBA 12/2010 - 01/2008
2	indium-bleomycinIBA 02/2024 - 08/2022
2	atezolizumabIBA 07/2023 - 01/2022
2	Indicators and Reagents (Reagents)IBA 01/2023 - 08/2018
2	fosaprepitant FDA Link 10/2022 - 06/2022
2	Fatty Acids (Saturated Fatty Acids)IBA 07/2022 - 01/2022
2	Propranolol (Inderal)FDA LinkGeneric 06/2022 - 01/2022
2	Muscarinic AntagonistsIBA 05/2022 - 02/2015
2	Serum AlbuminIBA 02/2022 - 12/2021

Therapy/Procedure

56	Therapeutics 04/2024 - 06/2002
26	Drug Therapy (Chemotherapy) 04/2024 - 08/2011
3	Aftercare (After-Treatment) 11/2023 - 06/2015
2	Drug Tapering 04/2024 - 08/2011
2	Cannula 11/2022 - 01/2020
2	Artificial Respiration (Mechanical Ventilation) 04/2022 - 06/2005